+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cervical Cancer"

From
Oncology Biomarkers: Global Markets - Product Thumbnail Image

Oncology Biomarkers: Global Markets

  • Report
  • June 2023
  • 186 Pages
  • Global
From
From
UAE Minimally Invasive Biopsy Techniques Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Thumbnail Image

UAE Minimally Invasive Biopsy Techniques Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • February 2025
  • 85 Pages
  • United Arab Emirates United Arab Emirates
From
From
From
From
Precision Oncology Market Report and Forecast 2023-2031 - Product Thumbnail Image

Precision Oncology Market Report and Forecast 2023-2031

  • Report
  • July 2023
  • 140 Pages
  • Global
From
From
From
Radiation Oncology Market Report and Forecast 2023-2031 - Product Thumbnail Image

Radiation Oncology Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
Neoplasia and Fertility - Product Thumbnail Image

Neoplasia and Fertility

  • Book
  • September 2022
From
Loading Indicator

Cervical cancer is a type of cancer that affects the cells of the cervix, the lower part of the uterus that connects to the vagina. It is the fourth most common cancer in women worldwide, and is caused by the human papillomavirus (HPV). Treatment for cervical cancer typically involves surgery, radiation therapy, chemotherapy, and targeted therapy. The cervical cancer market is a subset of the larger oncology market, which is composed of drugs, diagnostics, and services used to treat cancer. The cervical cancer market is expected to grow due to the increasing prevalence of HPV, the development of new treatments, and the increasing availability of healthcare services. Some companies in the cervical cancer market include Merck, Bristol-Myers Squibb, AstraZeneca, Roche, and Novartis. Show Less Read more